 |
PDBsum entry 2g1q
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Cell cycle
|
 |
|
Title:
|
 |
Crystal structure of ksp in complex with inhibitor 9h
|
|
Structure:
|
 |
Kinesin-like protein kif11. Chain: a, b. Synonym: kinesin-related motor protein eg5, kinesin-like spindle protein hksp, thyroid receptor-interacting protein 5, trip5, kinesin- like protein 1. Engineered: yes
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Gene: kif11, eg5, knsl1. Expressed in: escherichia coli bl21. Expression_system_taxid: 511693.
|
|
Resolution:
|
 |
|
2.51Å
|
R-factor:
|
0.234
|
R-free:
|
0.279
|
|
|
Authors:
|
 |
Y.Yan
|
|
Key ref:
|
 |
C.D.Cox
et al.
(2006).
Kinesin spindle protein (KSP) inhibitors. Part 4: Structure-based design of 5-alkylamino-3,5-diaryl-4,5-dihydropyrazoles as potent, water-soluble inhibitors of the mitotic kinesin KSP.
Bioorg Med Chem Lett,
16,
3175-3179.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
14-Feb-06
|
Release date:
|
03-Oct-06
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P52732
(KIF11_HUMAN) -
Kinesin-like protein KIF11 from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
1056 a.a.
330 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Bioorg Med Chem Lett
16:3175-3179
(2006)
|
|
PubMed id:
|
|
|
|
|
| |
|
Kinesin spindle protein (KSP) inhibitors. Part 4: Structure-based design of 5-alkylamino-3,5-diaryl-4,5-dihydropyrazoles as potent, water-soluble inhibitors of the mitotic kinesin KSP.
|
|
C.D.Cox,
M.Torrent,
M.J.Breslin,
B.J.Mariano,
D.B.Whitman,
P.J.Coleman,
C.A.Buser,
E.S.Walsh,
K.Hamilton,
M.D.Schaber,
R.B.Lobell,
W.Tao,
V.J.South,
N.E.Kohl,
Y.Yan,
L.C.Kuo,
T.Prueksaritanont,
D.E.Slaughter,
C.Li,
E.Mahan,
B.Lu,
G.D.Hartman.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Molecular modeling in combination with X-ray crystallographic information was
employed to identify a region of the kinesin spindle protein (KSP) binding site
not fully utilized by our first generation inhibitors. We discovered that by
appending a propylamine substituent at the C5 carbon of a dihydropyrazole core,
we could effectively fill this unoccupied region of space and engage in a
hydrogen-bonding interaction with the enzyme backbone. This change led to a
second generation compound with increased potency, a 400-fold enhancement in
aqueous solubility at pH 4, and improved dog pharmacokinetics relative to the
first generation compound.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
C.Jiang,
Q.You,
F.Liu,
W.Wu,
Q.Guo,
J.Chern,
L.Yang,
and
M.Chen
(2009).
Design, synthesis and evaluation of tetrahydroisoquinolines as new kinesin spindle protein inhibitors.
|
| |
Chem Pharm Bull (Tokyo),
57,
567-571.
|
 |
|
|
|
|
 |
D.Huszar,
M.E.Theoclitou,
J.Skolnik,
and
R.Herbst
(2009).
Kinesin motor proteins as targets for cancer therapy.
|
| |
Cancer Metastasis Rev,
28,
197-208.
|
 |
|
|
|
|
 |
O.Mahé,
D.Frath,
I.Dez,
F.Marsais,
V.Levacher,
and
J.F.Brière
(2009).
TBD-organocatalysed synthesis of pyrazolines.
|
| |
Org Biomol Chem,
7,
3648-3651.
|
 |
|
|
|
|
 |
C.Jiang,
Y.Chen,
X.Wang,
and
Q.You
(2007).
Docking studies on kinesin spindle protein inhibitors: an important cooperative 'minor binding pocket' which increases the binding affinity significantly.
|
| |
J Mol Model,
13,
987-992.
|
 |
|
|
|
|
 |
I.Garcia-Saez,
S.DeBonis,
R.Lopez,
F.Trucco,
B.Rousseau,
P.Thuéry,
and
F.Kozielski
(2007).
Structure of human Eg5 in complex with a new monastrol-based inhibitor bound in the R configuration.
|
| |
J Biol Chem,
282,
9740-9747.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
L.Luo,
C.A.Parrish,
N.Nevins,
D.E.McNulty,
A.M.Chaudhari,
J.D.Carson,
V.Sudakin,
A.N.Shaw,
R.Lehr,
H.Zhao,
S.Sweitzer,
L.Lad,
K.W.Wood,
R.Sakowicz,
R.S.Annan,
P.S.Huang,
J.R.Jackson,
D.Dhanak,
R.A.Copeland,
and
K.R.Auger
(2007).
ATP-competitive inhibitors of the mitotic kinesin KSP that function via an allosteric mechanism.
|
| |
Nat Chem Biol,
3,
722-726.
|
 |
|
|
|
|
 |
S.Manyem,
M.P.Sibi,
G.H.Lushington,
B.Neuenswander,
F.Schoenen,
and
J.Aubé
(2007).
Solution-phase parallel synthesis of a library of delta(2)-pyrazolines.
|
| |
J Comb Chem,
9,
20-28.
|
 |
|
|
|
|
 |
J.C.Cochran,
T.C.Krzysiak,
and
S.P.Gilbert
(2006).
Pathway of ATP hydrolysis by monomeric kinesin Eg5.
|
| |
Biochemistry,
45,
12334-12344.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |